LAXMI SANKALPA BHAGANAGARAPU and SARUMATHY SUNDARARAJAN (2025) “NOVEL APPROACHES FOR ANEMIA IN CARDIORENAL SYNDROME: A RANDOMIZED CONTROLLED TRIAL OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR VS SGLT2 INHIBITOR”, Asian Journal of Pharmaceutical and Clinical Research, 18(12), pp. 184–191. doi: 10.22159/ajpcr.2025v18i12.57009.